Health-care problems of Turner syndrome in the adult woman: A cross sectional study of a Victorian cohort and a case for transition

Internal Medicine Journal

Volumn 36, Issue 1, 2006, Pages 54-57

  Pedreira, C C ^a   Hameed, R ^a   Kanumakala, S ^b   Zacharin, M ^a  

^a ROYAL CHILDREN'S HOSPITAL   (Australia)

^b ALEXANDRA HOSPITAL   (United Kingdom)

Author keywords

Adulthood; Comorbidities; Turner syndrome

Indexed keywords

ANTIHYPERTENSIVE AGENT; ESTROGEN; GROWTH HORMONE; ORAL CONTRACEPTIVE AGENT;

ADOLESCENT; ADULT; ARTICLE; AUSTRALIA; BODY MASS; CARDIOVASCULAR DISEASE; CELIAC DISEASE; CLINICAL ARTICLE; COHORT ANALYSIS; COMORBIDITY; DIABETES MELLITUS; DYSLIPIDEMIA; ESTROGEN THERAPY; FEMALE; FRACTURE; HEARING LOSS; HORMONE DEFICIENCY; HORMONE SUBSTITUTION; HUMAN; HYPERTENSION; OBESITY; PRIORITY JOURNAL; THYROID DISEASE; TURNER SYNDROME;

ADOLESCENT; ADULT; COMORBIDITY; CROSS-SECTIONAL STUDIES; FEMALE; HUMAN GROWTH HORMONE; HUMANS; TURNER SYNDROME; VICTORIA;

EID: 33644834911     PISSN: 14440903     EISSN: 14455994     Source Type: Journal    
DOI: 10.1111/j.1445-5994.2005.00990.x     Document Type: Article

References (23)

1. Lippe B. Turner syndrome. Endocr Metab Clin North Am 1991; 20: 121-52.
2. Elsheikh M, Dunger DB, Conway GS, Wass JA. Turner's syndrome in adulthood. Endocr Rev 2002; 23: 120-40.
3. Gravholt CH. Epidemological, endocrine and metabolic features in Turners Syndrome. Eur J Endocrinol 2004; 151: 657-87.
4. Gravholt CH, Juul S, Naeraa RW, Hansen J. Morbidity in Turner syndrome. J Clin Epidemiol 1998; 51: 147-58.
5. Verlinde F, Massa G, Lagrou K, Froidecoeur C, Bourguignon JP, Craen M et al. Health and psychosocial status of patients with Turner syndrome after transition to adulthood. Horm Res 2004; 62: 161-7.
6. Poole R, Leatherdale B. An audit of adult women with Turner's syndrome - is surveillance for comorbidity adequate? Clin Endocrinol 2002; 56: 561-2.
7. Henry LW, Gardin JM, Ware JH. Echocardiographic measurements in normal subjects from infancy to old age. Circulation 1990; 62: 1054-6.
8. Saenger P, Wikland KA, Conway GS, Davenport M, Gravholt CH, Hintz R et al. Recommendations for the diagnosis and management of Turner syndrome. J Endocrinol Metab Clin 2001; 86: 3061-9.
9. Price WH, Clayton JF, Collyer S, De Mey R, Wilson J. Mortality ratios, life expectancy, and causes of death in patients with Turner's syndrome. J Epidemiol Community Health 1986; 40: 97-102.
10. Prandstraller D, Mazzanti L, Pichio FM, Magnani C, Bergamaschi R, Perri A et al. Turner's syndrome: cardiologic profile according to the different chromosomal patterns and long term clinical follow-up of 136 nonpreselected patients. Pediatr Cardiol 1999; 2: 108-12.
11. Pasquino AM, Passeri F, Pucarelli I, Segni M, Municchi G. Spontaneous pubertal development in Turner's syndrome. Italian Study Group for Turner's syndrome. J Clin Endo crinol Metab 1997; 82: 1810-13.
12. Hovatta O. Pregnancies in women with Turner's syndrome. Ann Med 1999; 31: 106-10.
13. Illig R, DeCampo C, Lang-Muritano MR, Prader A, Torresani T, Werder EA et al. A physiological mode of puberty induction in hypogonadal girls by low dose transdermal 17 beta-oestradiol. Eur J Pediatr 1990; 150: 86-91.
14. Jospe N, Orlowski CC, Furlanetto RW. Comparison of transdermal and oral estrogen therapy in girls with Turner's syndrome. J Pediatr Endocrinol Metab 1995; 8: 111-16.
15. Ankarberg-Lindgren K, Elfving M, Albertsson-Wikland KA, Norjavaara E. Nocturnal application of transdermal estradiol patches produces levels of estradiol that mimic those seen in at the onset of spontaneous puberty in girls. J Clin Endocrinol Metab 2001; 86: 3039-44.
16. Zacharin M. Use of androgens and oestrogens in adolescents - a review of hormone replacement treatment. J Pediatr Endocrinol Metab 2000; 13: 3-11.
17. Conway GS. Oestrogen replacement in young women with Turner's syndrome. Clin Endocrinol 2001; 54: 157-8.
18. McDonnell CM, Coleman L, Zacharin MR. A 3-year prospective study to assess uterine growth in girls with Turner's syndrome by pelvic ultrasound. Clin Endocrinol 2003; 58: 446-50.
19. Snajderova M, Mardesic T, Lebl J, Gerzova H, Teslik L, Zapletalova J et al. The uterine length in women with Turner Syndrome reflects the postmenarcheal daily estrogen dose. Harm Res 2003; 60: 198-204.
20. Landin-Wilhelmsen K, Bryman I, Wind M, Wilhelmsen L. Osteoporosis and fractures in Turner syndrome-importance of growth promoting and oestrogen therapy. Clin Endocrinol 1999; 51: 497-502.
21. Sass TC, Muinck Keizer-Schrama SM, Stijnen T, Asarfi A, Leeuwen WJV, Teunenbroek AV et al. A longitudinal study on bone mineral density until adulthood in girls with Turner's syndrome participating in a growth hormone injection frequency-response trial. Clin Endocrinol 2000; 52: 531-6.
22. Hogler W, Briody J, Moore B, Garnett S, Lu PW, Cowell CT. Importance of estrogen on bone health in Turner syndrome: a cross sectional study using dual energy X ray absorptiometry. J Clin Endocrinol Metab 2004; 89: 193-9.
23. Conway GS. Considerations for transition from pediatric to adult endocrinology: women with Turner's syndrome. Growth Harm IGF Res 2004; 14: 77-84.